Behavioral science and pandemic management - A:care HCP Malaysia
Skip to content
Home > Behavioral science and pandemic management

Behavioral science and pandemic management

Behavioral science perspective on pandemic outbreak management.

This masterclass covers the management of the pandemic from a behavioral science perspective. It looks into the importance of continued adherence during a global pandemic and how to change behavior at short notice. 

Read more on this topic:


About Kevin Dolgin

Kevin Dolgin is the Co-Founder of Observia – an organisation that designs and manages patient adherence programs in France, as well as providing research and consulting about patient support throughout the world. 

Kevin is also a part-time professor at IAE in Paris (Université de Paris I, Panthéon-Sorbonne), Via IAE he has also taught in business schools in Vietnam and China, as well as for the Global Partners MBA program in partnership with the University of Atlanta (USA). 

Kevin has been a speaker and chairperson in numerous pharmaceutical conferences, including Eye For Pharma’s events. He has also published numerous articles in trade magazines on salesforce effectiveness, patient adherence, and the role of services management in pharmaceuticals, change management, and the use of simulations in training. His articles have appeared throughout the world in over ten languages. He has also authored or co-authored two white papers about patient adherence and has been published in the European Journal of Person-Centered Healthcare.

Share this post

Read more on this topic

Session: Closing congress first day

Session: Patient perspectives of adherence and how these can help us improve…

Session: International Society of Gynecological Endocrinology – From treating…

Session: International Society of Hypertension – Raising awareness on…

Session: Practical individual interventions any healthcare professionals can…

Session: The challenge and causes of non-adherence

Session: Consequences of non-adherence to narrow therapeutic index drugs

Session: The paradox of non-adherence to treatment in oncology

Session: Non-adherence is the new cardiovascular risk factor

Session: Welcome and congress introduction

Behavioral frameworks for understanding patient adherence

How healthcare providers can address non-adherence